Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 753,751 | 511,495 | 354,947 | 297,059 | 94,455 |
| Cost of Goods | 26,972 | 3,004 | 630 | 157 | N/A |
| Gross Profit | 726,779 | 508,491 | 354,317 | 296,902 | 94,455 |
| Operating Expenses | 677,100 | 513,299 | 371,049 | 295,911 | 237,638 |
| Operating Income | 50,651 | -4,804 | -16,102 | 1,148 | -143,183 |
| Interest Expense | 45,603 | 46,828 | 38,652 | 46,058 | 43,819 |
| Other Income | 2,508 | 3,085 | -28,094 | 764 | 462 |
| Pre-tax Income | 7,556 | -48,547 | -82,848 | -44,146 | -186,540 |
| Income Tax | 1,025 | -66 | 299 | 174 | N/A |
| Net Income Continuous | 6,531 | -48,481 | -83,147 | -44,320 | -186,540 |
| Net Income | $6,531 | $-48,481 | $-83,147 | $-44,320 | $-186,540 |
| EPS Basic Total Ops | 0.04 | -0.29 | -0.56 | -0.34 | -1.49 |
| EPS Basic Continuous Ops | 0.04 | -0.29 | -0.56 | -0.34 | -1.49 |
| EPS Diluted Total Ops | 0.03 | -0.29 | -0.56 | -0.34 | -1.49 |
| EPS Diluted Continuous Ops | 0.03 | -0.29 | -0.56 | -0.34 | -1.49 |
| EBITDA(a) | $95,534 | $36,609 | $13,105 | $31,127 | $-116,193 |